[Activities of specific phosphatases, nonspecific esterases and transpeptidases in neoplastic plasmacytes before and after treatment with Alkeran].
D000217:Acyltransferases / Q000032:analysis*; D000251:Adenosine Triphosphatases / Q000032:analysis*; D001859:Bone Neoplasms / Q000201:enzymology*; D004950:Esterases / Q000032:analysis*; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000201:enzymology; D010950:Plasma Cells / Q000201:enzymology; D010954:Plasmacytoma / Q000188:drug therapy / Q000201:enzymology*
D000217:Acyltransferases; D004950:Esterases; D000251:Adenosine Triphosphatases; D008558:Melphalan
Zachowanie sie aktywności swoistych fosfataz, esteraz niewoistych i transpeptidaz w plazmocytach nowotworowych przed- i po leczeniu Alkeranem.